Conclusion
Based on our recent data (37,54,56) and the association that profound alterations in βAR signaling are found in chronic end-stage human heart failure (64), it is possible that defects in this pathway are primary elements that underlie the transition from compensated to decompensated cardiac failure. Decreasing the level of myocardial βARK1 in established heart failure, is a novel approach to improving impaired βAR receptor function and potentially alter the pathogenesis in this disease.
Similar content being viewed by others
References
Langer, G. A. and Peskoff, A. (1997) Role of the diadic cleft in myocardial contractile control.Circulation 96, 3761–3765.
Gether, U. and Kobilka, B. K. (1998) G protein-coupled receptors. II. mechanism of agonist activation.J. Biol. Chem. 273, 17,979–17,982.
Barry, W. H. and Bridge, J. H. (1993) Intracellular calcium homeostasis in cardiac myocytes.Circulation 87, 1806–1815.
Ji, T. H., Grossmann, M., and Ji, I. (1998) G Protein-coupled receptors. I. Diversity of receptor-ligand interactions.J. Biol. Chem. 273, 17,299–17,302.
Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D., and Dixon, R. A. (1994) Structure and function of G protein-coupled receptors.Annu. Rev. Biochem. 63, 101–132.
Hein, L. and Kobilka, B. K. (1995) Adrenergic receptor signal transduction and regulation.Neuropharmacology 34, 357–366.
Rockman, H. A., Koch, W. J., and Lefkowitz, R. J. (1997) Cardiac function in genetically engineered mice with altered adrenergic receptor signaling.Am. J. Physiol. 272, H1553-H1559.
Lefkowitz, R. J. (1998) G protein-coupled receptors. III. New roles for receptor kinases and b-arrestins in receptor signaling and desensitization.J. Biol. Chem. 273, 18,677–18,680.
Lefkowitz, R. J. (1993) G-protein-coupled receptor kinases.Cell 74, 409–412.
Lohse, M. J., Krasel, C., Winstel, R., and Mayor, F., Jr. (1996) G-protein-coupled receptor kinases.Kidney Int. 49, 1047–1052.
Lohse, M. J. (1993) Molecular mechanisms of membrane receptor desensitization.Biochim. Biophys. Acta. 1179, 171–188.
Hausdorff, W. P., Caron, M. G., and Lefkowitz, R. J. (1990) Turning off the signal: desensitization of beta-adrenergic receptor function.FASEB J. 4, 2881–2889.
Freedman, N. J., Liggett, S. B., Drachman, D. E., Pei, G., Caron, M. G., and Lefkowitz, R. J. (1995) Phosphorylation and desensitization of the human beta1-adrenergic receptor. Involvement of G protein-coupled receptor kinases and cAMP-dependent protein kinase.J. Biol. Chem. 270, 17,953–17,961.
Fredericks, Z. L., Pitcher, J. A., and Lefkowitz, R. J. (1996) Identification of the G protein-coupled receptor kinase phosphorylation sites in the human beta2-adrenergic receptor.J. Biol. Chem. 271, 13,796–13,803.
Inglese, J., Freedman, N. J., Koch, W. J., and Lefkowitz, R. J. (1993) Structure and mechanism of the G protein-coupled receptor kinases.J. Biol. Chem. 268, 23,735–23,738.
Daaka, Y., Luttrell, L. M., and Lefkowitz, R. J. (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.Nature 390, 88–91.
Pitcher, J. A., Inglese, J., Higgins, J. B., Arriza, J. L., Casey, P. J., Kim, C., Benovic, J. L., Kwatra, M. M., Caron, M. G., and Lefkowitz, R. J. (1992) Role of beta gamma subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane-bound receptors.Science 257, 1264–1267.
Koch, W. J., Inglese, J., Stone, W. C., and Lefkowitz, R. J. (1993) The binding site for the beta gamma subunits of heterotrimeric G proteins on the beta-adrenergic receptor kinase.J. Biol. Chem. 268, 8256–8260.
Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., and Lefkowitz, R. J. (1990) β-Arrestin: a protein that regulates β-adrenergic receptor function.Science 248, 1547–1550.
Goodman, O. B., Jr., Krupnick, J. G., Santini, F., Gurevich, V. V., Penn, R. B., Gagnon, A. W., Keen, J. H., and Benovic, J. L. (1996) Betaarrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.Nature 383, 447–450.
Ferguson, S. S., Downey, W. E., 3rd., Colapietro, A. M., Barak, L. S., Menard, L., and Caron, M. G. (1996) Role of beta-arrestin in mediating agonist-promoted G protein-coupled receptor internalization.Science 271, 363–366.
Clapham, D. E. and Neer, E. J. (1993) New roles for G-protein beta gamma-dimers in transmembrane signalling.Nature 365, 403–406.
Nair, L. A., Inglese, J., Stoffel, R., Koch, W. J., Lefkowitz, R. J., Kwatra, M. M., and Grant, A. O. (1995) Cardiac muscarinic potassium channel activity is attenuated by inhibitors of G beta gamma.Circ. Res. 76, 832–838.
Gutkind, J. S. The pathways connecting G protein-coupled receptors to the nucleus through divergent mitogen-activated protein kinase cascades.J. Biol. Chem. 273, 1839–1842.
Daaka, Y., Pitcher, J. A., Richardson, M., Stoffel, R. H., Robishaw, J. D., and Lefkowitz, R. J. (1997) Receptor and G betagamma isoform-specific interactions with G protein-coupled receptor kinases.Proc. Natl. Acad. Sci. USA 94, 2180–2185.
Grossman, W., Jones, D., and McLaurin, L. P. (1975) Wall stress and patterns of hypertrophy in the human left ventricle.J. Clin. Invest. 56, 56–64.
Lorell, B. H. (1997) Transition from hypertrophy to failure.Circulation 96, 3824–3827.
Eichhorn, E. J. and Bristow, M. R. (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure.Circulation 94, 2285–2296.
Force, T. and Bonventre, J. V. (1998) Growth factors and mitogen activated protein kinases.Hypertension 31, 152–161.
Gomez, A. M., Valdivia, H. H., Cheng, H., Lederer, M. R., Santana, L. F., Cannell, M. B., McCune, S. A., Altschuld, R. A., and Lederer, W. J. (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure.Science 276, 800–806.
Post, G. R. and Brown, J. H. (1996) G protein-coupled receptors and signaling pathways regulating growth responses.FASEB J. 10, 741–749.
D’Angelo, D. D., Sakata, Y., Lorenz, J. N., Boivin, G. P., Walsh, R. A., Liggett, S. B., and Dorn, GWn. (1997) Transgenic Galphaq over-expression induces cardiac contratile failure in mice.Proc. Natl. Acad. Sci. USA 94, 8121–8126.
Akhter, S. A., Luttrell, L. M., Rockman, H. A., Iaccarino, G., Lefkowitz, R. J., and Koch, W. J. (1998) Targeting the receptor-G(q) interface to inhibit in vivo pressure overload myocardial hypertrophy.Science 280, 574–577.
Bohm, D., Moll, M., Schmid, B., Paul, M., Ganten, D., Castellano, M., and Erdmann, E. (1994) Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.Hypertension 24, 653–662.
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., Jr., and Chien, K. R. (1991) Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy.Proc. Natl. Acad. Sci. USA 88, 8277–8281.
Rockman, H. A., Knowlton, K. U., Ross, J., Jr. and Chien, K. R. (1993) In vivo murine cardiac hypertrophy. A novel model to identify genetic signaling mechanisms that activate an adaptive physiological response.Circulation 87, VII-14–VII-21.
Choi, D. J., Koch, W. J., Hunter, J. J., and Rockman, H. A. (1997) Mechanism of betaadrenergic receptor desensitization in cardiac hypertrophy is increased beta-adrenergic receptor kinase.J. Biol. Chem. 272, 17223–17229.
Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R. A., Bond, R. A., Milano, C. A., and Lefkowitz, R. J. (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.Science 268, 1350–1353.
Leimbach, W. N., Jr., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlof, G., and Mark, A. L. (1986) Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.Circulation 73, 913–919.
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., and Rector, T. (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.N. Engl. J. Med. 311, 819–823.
Francis, G. S., Benedict, C., Johnstone, D. E., Kirlin, P. C., Nicklas, J., Liang, C. S., Kubo, S. H., Rudin-Toretsky, E., and Yusuf, S. (1990) Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation 82, 1724–1729.
Rockman, H. A., Juneau, C., Chatterjee, K., and Rouleau, J. L. (1989) Long-term predictors of sudden and low output death in chronic congestive heart failure secondary to coronary artery disease.Am. J. Cardiol. 64, 1344–1348.
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., and Stinson, E. B. (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.N. Engl. J. Med. 307, 205–211.
Feldman, A. M. (1993) Modulation of adrenergic receptors and G-transduction proteins in failing human ventricular myocardium.Circulation 87, IV27-IV34.
Ungerer, M., Parruti, G., Bohm, M., Puzicha, M., DeBlasi, A., Erdmann, E., and Lohse, M. J. (1994) Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart.Circ. Res. 74, 206–213.
Gros, R., Benovic, J. L., Tan, C. M., and Feldman, R. D. (1997) G-protein-coupled receptor kinase activity is increased in hypertension.J. Clin. Invest. 99, 2087–2093.
Ungerer, M., Kessebohm, K., Kronsbein, K., Lohse, M. J., and Richardt, G. (1996) Activation of beta-adrenergic receptor kinase during myocardial ischemia.Circ. Res. 79, 455–460.
Brodde, O. E. (1993) Beta-adrenoceptors in cardiac disease.Pharmacol. Ther. 60, 405–430.
Ungerer, M., Bohm, M., Elce, J. S., Erdmann, E., and Lohse, M. J. (1993) Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.Circulation 87, 454–463.
Rockman, H. A., Choi, D. J., Rahman, N. U., Akhter, S. A., Lefkowitz, R. J., and Koch, W. J. (1996) Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice.Proc. Natl. Acad. Sci. USA 93, 9954–9959.
Ping, P., Gelzer-Bell, R., Roth, D. A., Kiel, D., Insel, P. A., and Hammond, H. K. (1995) Reduced beta-adrenergic receptor activation decreases G-protein expression and beta-adrenergic receptor kinase activity in porcine heart.J. Clin. Invest. 95, 1271–1280.
Iaccarino, G., Tomhave E. D., Lefkowitz, R. J., and Koch, W. J. (1998) Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade.Circulation 98, 1783–1789.
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., and Shusterman, N. H. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.N. Engl. J. Med. 334, 1349–1355.
Rockman, H. A., Choi, D. J., Akhter, S. A., Jaber, M., Giros, B., Lefkowitz, R. J., Caron, M. G., and Koch, W. J. (1998) Control of myocardial contractile function by the level of β-adrenergic receptor kinasel in gene-targeted mice.J. Biol. Chem. 273, 18,180–18,184.
Jaber, M., Koch, W. J., Rockman, H. A., Smith, B., Bond, R. A., Sulik, K., Ross, J., Jr., Lefkowitz, R. J., Caron, M. G., and Giros, B. (1996) Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function.Proc. Natl. Acad. Sci USA 93, 12,974–12,979.
Rockman, H. A., Chien, K. R., Choi, D. J., Iaccarino, G., Hunter, J. J., Ross, J., Jr., Lefkowitz, R. J., and Koch, W. J. (1998) Expression of a β-adrenergic receptor kinasel inhibitor prevents the development of heart failure in gene-targeted mice.Proc. Natl. Acad. Sci. USA 95, 7000–7005.
Milano, C. A., Allen, L. F., Rockman, H. A., Dolber, P. C., McMinn, T. R., Chien, K. R., Johnson, T. D., Bond, R. A., and Lefkowitz, R. J. (1994) Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor.Science 264, 582–586.
Arber, S., Hunter, J. J., Ross, J., Jr., Hongo, M., Sansig, G., Borg, J., Perriard, J.-C., Chien, K. R., and Caroni, P. (1997) MLP-deficient mice exhibit a disruption of cardiac cytoarchitecture organization, dilated cardiomyopathy, and heart failure.Cell 88, 393–403.
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.N. Engl. J. Med. 325, 1468–1475.
Tang, W. J. and Gilman, A. G. (1992) Adenylyl cyclases.Cell 70, 869–872.
Pitcher, J. A., Freedman, N. J., and Lefkowitz, R. J. (1998) G protein-coupled receptor kinases.Ann. Rev. Biochem. 67, 653–692.
Luttrell, L. M., Daaka, Y., Della Rocca, G. J., and Lefkowitz, R. J. (1997) G protein-coupled receptors mediate two functionally distinct pathways of tyrosine phosphorylation in rat 1a fibroblasts. Shc phosphorylation and receptor endocytosis correlate with activation of Erk kinases.J. Biol. Chem. 272, 31,648–31,656.
Pitcher, J. A., Hall, R. A., Daaka, Y., Zhang, J., Ferguson, S. S., Hester, S., Miller, S., Caron, M. G., Lefkowitz, R. J., and Barak, L. S. (1998) The G protein-coupled receptor kinase 2 is a microtubule-associated protein kinase that phosphorylates tubulin.J. Biol. Chem. 273, 12,316–12,324.
Brodde, O. E., Vogelsang, M., Broede, A., Michel-Reher, M., Beisenbusch-Schafer, E., Hakim, K., and Zerkowski, H. R. (1998) Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy.J. Cardiovasc. Pharmacol. 31, 585–594.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Choi, DJ., Rockman, H.A. β-adrenergic receptor desensitization in cardiac hypertrophy and heart failure. Cell Biochem Biophys 31, 321–329 (1999). https://doi.org/10.1007/BF02738246
Issue Date:
DOI: https://doi.org/10.1007/BF02738246